ロード中...
Extended treatment with fingolimod for relapsing multiple sclerosis: the 14-year LONGTERMS study results
BACKGROUND: Multiple sclerosis (MS) is a chronic disease that may require decades of ongoing treatment. Therefore, the long-term safety and efficacy of disease-modifying therapies is an important consideration. METHODS: The LONGTERMS study evaluated the safety and efficacy of fingolimod in patients...
保存先:
| 出版年: | Ther Adv Neurol Disord |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6763939/ https://ncbi.nlm.nih.gov/pubmed/31598139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286419878324 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|